Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
about
Sex differences in the incidence of skin and skin-related diseases in Olmsted County, Minnesota, United States, and a comparison with other rates published worldwideCost of illness studies on reproductive, maternal, newborn, and child health: a systematic literature reviewHPV Infection-Associated Cancers: Next-Generation Technology for Diagnosis and TreatmentEstimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in EuropeSystematic review of the incidence and prevalence of genital warts.A retrospective analysis of the costs and management of genital warts in Italy.Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study.Genital warts and cost of care in EnglandRisk factors for incident condyloma in a multinational cohort of men: the HIM study.Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.EUROGIN 2011 roadmap on prevention and treatment of HPV-related diseaseGenital HPV infection and related lesions in menCoexisting high-grade vulvar intraepithelial neoplasia (VIN) and condyloma acuminatum: independent lesions due to different HPV types occurring in immunocompromised patientsSafety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b triFactors associated with early adoption of the HPV vaccine in US male adolescents include Hispanic ethnicity and receipt of other vaccinesThe impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model.Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis.Economic and humanistic burden of external genital warts.Acceptability of the human papillomavirus vaccine among urban adolescent males.HPV vaccination of boys in primary care practices.A cross-sectional study estimating the burden of illness related to genital warts in South Korea.Correlates to Human Papillomavirus Vaccination Status and Willingness to Vaccinate in Low-Income Philadelphia High School Students.Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States.Knowledge of sexually transmitted HPV infection, genitoanal warts, cancer and their prevention among young females after vaccine introduction in Germany.Human papillomavirus vaccine initiation and awareness: U.S. young men in the 2010 National Health Interview Survey.Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination.
P2860
Q30251721-AA175CAE-6939-4612-A8C0-514219D212EAQ34253898-53DE92A4-EC81-4618-ABC7-915F16FA789EQ34290170-4D9B6EC8-7BD8-44C3-9264-13416010ED72Q34539349-19B6A900-20F9-4F1A-9985-7E5DD84FEB84Q34561142-D06C2F84-67DE-4055-829E-5897502D2578Q35012491-E5D07F8A-7304-4C37-BC1E-887173CB45DDQ35532844-B4B74340-D50A-461B-8143-3ABC6314171DQ35658387-3A8166FD-D8F8-4AFB-95AD-C37E296A70E6Q35741949-D12B7F55-E436-4EBC-B1AF-4CA409A0D0CEQ35851444-CABB2FCD-A025-4DBD-9C39-2D7FC2717870Q36194955-7BE2C1B1-8722-48C4-AEAB-FA28B5E76207Q36389950-8E45DB33-5F4F-4962-8B74-35E306DE5AD9Q36472797-2DB71CCA-05E6-4E45-99E3-FA556632C42CQ36954152-3B552ADC-A4E4-4245-8FDB-887E5E6A9B92Q37056623-CC744341-2695-470C-8CB0-359691C2D398Q37135272-2A341DDF-BEB3-4BD9-A304-ECB15F4FEEFFQ37696770-8A3A15EA-1343-4C36-84D0-1EB3C547C8D9Q37971472-EDD0328D-C667-40FD-A71A-A087ECDA60B0Q40056557-5A8C72B9-7C92-45DA-84BC-E966D8ED6B83Q40135675-1F629A52-0D04-4724-A819-EC56EDAC7CBFQ40148441-01D509FB-6839-4775-BF28-E7A740468A67Q40294202-A6F92A4F-6ABC-4BCD-8D73-42DC67A3571EQ40464632-B9362E1D-1B6A-417F-95EF-08B140C400C3Q43858038-A907BC84-5959-4C26-BB78-3D6A5C8D4386Q46002230-5F750820-1525-4855-927B-53FBC58F1F14Q51872328-BEF14BAA-059C-466D-B579-87C6C8EE25EA
P2860
Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Assessing incidence and econom ...... mmercially insured population.
@ast
Assessing incidence and econom ...... mmercially insured population.
@en
type
label
Assessing incidence and econom ...... mmercially insured population.
@ast
Assessing incidence and econom ...... mmercially insured population.
@en
prefLabel
Assessing incidence and econom ...... mmercially insured population.
@ast
Assessing incidence and econom ...... mmercially insured population.
@en
P2093
P1476
Assessing incidence and econom ...... mmercially insured population.
@en
P2093
Puneet K Singhal
Ralph P Insinga
Tracey Hoy
Vincent J Willey
P304
P356
10.1185/03007990903136378
P407
P577
2009-10-01T00:00:00Z